{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:14Z","timestamp":1787698154380,"version":"build-2784847793"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Quebec Sante","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ymthe.2022.01.020","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T11:44:06Z","timestamp":1642419846000},"page":"1500-1522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Passive immunization against phosphorylated tau improves features of Huntington's disease pathology"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2782-5454","authenticated-orcid":false,"given":"Melanie","family":"Alpaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masnata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5548-8045","authenticated-orcid":false,"given":"Aurelie","family":"de Rus Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-3433","authenticated-orcid":false,"given":"Eva","family":"Lepinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8na L.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Saint-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Planel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1961","authenticated-orcid":false,"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.01.020_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","article-title":"Huntington's disease","volume":"25","author":"Ha","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/nmt.12.34","article-title":"Monitoring Huntington's disease progression through preclinical and early stages","volume":"2","author":"Tang","year":"2012","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.ymthe.2022.01.020_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","article-title":"Behavioural abnormalities contribute to functional decline in Huntington's disease","volume":"74","author":"Hamilton","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2022.01.020_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/exnr.1998.7005","article-title":"Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein","volume":"156","author":"Sieradzan","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib5","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.01.020_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.24174","article-title":"Mutant huntingtin is present in neuronal grafts in Huntington disease patients","volume":"76","author":"Cicchetti","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","article-title":"Huntington's disease: the current state of research with peripheral tissues","volume":"219","author":"Sassone","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib8","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/cddis.2012.121","article-title":"An in\u00a0vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity","volume":"3","author":"Cisbani","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington's disease a tauopathy?","volume":"139","author":"Gratuze","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2022.01.020_bib10","doi-asserted-by":"crossref","first-page":"580732","DOI":"10.3389\/fneur.2020.580732","article-title":"Targeting tau to treat clinical features of huntington's disease","volume":"11","author":"Masnata","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2022.01.020_bib12","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.5245-10.2011","article-title":"Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant","volume":"31","author":"Sydow","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/369488a0","article-title":"Altered microtubule organization in small-calibre axons of mice lacking tau protein","volume":"369","author":"Harada","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.020_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib16","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1021\/bi00552a027","article-title":"Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins","volume":"19","author":"Jameson","year":"1980","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2022.01.020_bib17","doi-asserted-by":"crossref","first-page":"e2206","DOI":"10.1038\/cddis.2016.104","article-title":"GSK-3beta-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions","volume":"7","author":"L'Episcopo","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib18","doi-asserted-by":"crossref","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","article-title":"An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease","volume":"288","author":"Cavallini","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/hmg\/ddu456","article-title":"Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease","volume":"24","author":"Gratuze","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.01.020_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","article-title":"Defective brain microtubule assembly in Alzheimer's disease","volume":"2","author":"Iqbal","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2022.01.020_bib21","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","article-title":"Phosphorylation affects the ability of tau protein to promote microtubule assembly","volume":"259","author":"Lindwall","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib22","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.febslet.2006.02.067","article-title":"Tau phosphorylation and aggregation in Alzheimer's disease pathology","volume":"580","author":"Avila","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2022.01.020_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington's disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington's disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2022.01.020_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s007020050095","article-title":"Alzheimer-type lesions in Huntington's disease","volume":"105","author":"Jellinger","year":"1998","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.ymthe.2022.01.020_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters Tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.01.020_bib28","doi-asserted-by":"crossref","first-page":"e0135774","DOI":"10.1371\/journal.pone.0135774","article-title":"Passive immunization in JNPL3 transgenic mice using an array of phospho-tau specific antibodies","volume":"10","author":"d'Abramo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.020_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib30","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","article-title":"Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model","volume":"30","author":"Boutajangout","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib31","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.020_bib32","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2022.01.020_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jalz.2017.01.028","article-title":"Cognitive decline associated with pathological burden in primary age-related tauopathy","volume":"13","author":"Jefferson-George","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2022.01.020_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12248","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"25","author":"McKee","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nlm.2009.02.002","article-title":"Intrasession and intersession habituation in mice: from inbred strain variability to linkage analysis","volume":"92","author":"Bolivar","year":"2009","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fnins.2020.00082","article-title":"Cortical and striatal circuits in huntington's disease","volume":"14","author":"Blumenstock","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib39","series-title":"The Neuropathology of Huntington\u2019s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy","first-page":"25","article-title":"The cerebral cortex in Huntington\u2019s disease (HD)","author":"R\u00fcb","year":"2015"},{"key":"10.1016\/j.ymthe.2022.01.020_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc0655","article-title":"The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography","volume":"13","author":"Sanchez","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.020_bib41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"Rub","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nlm.2010.12.005","article-title":"Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission","volume":"95","author":"Van der Jeugd","year":"2011","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-020-00896-8","article-title":"Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy","volume":"8","author":"Zheng","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2022.01.020_bib44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1460-9568.2005.04290.x","article-title":"Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism","volume":"22","author":"Elliott","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ymthe.2022.01.020_bib46","doi-asserted-by":"crossref","first-page":"46359","DOI":"10.1038\/srep46359","article-title":"Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology","volume":"7","author":"Gratuze","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib47","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbadis.2004.06.017","article-title":"Tau phosphorylation: physiological and pathological consequences","volume":"1739","author":"Stoothoff","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2022.01.020_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12974-017-0871-0","article-title":"Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity","volume":"14","author":"Kirkley","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2022.01.020_bib50","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2020.01818","article-title":"Affective immunology: the crosstalk between microglia and astrocytes plays key role?","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in huntington's disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib52","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.ymthe.2022.01.020_bib53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib54","doi-asserted-by":"crossref","first-page":"e0148839","DOI":"10.1371\/journal.pone.0148839","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of huntington's disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.020_bib55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1750-3639.2010.00466.x","article-title":"Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis","volume":"21","author":"Schirmer","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.stemcr.2019.07.015","article-title":"CTIP2-Regulated reduction in PKA-dependent DARPP32 phosphorylation in human medium spiny neurons: implications for Huntington disease","volume":"13","author":"Fjodorova","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib57","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.020_bib58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrn2969","article-title":"From glutamate co-release to vesicular synergy: vesicular glutamate transporters","volume":"12","author":"El Mestikawy","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","article-title":"A brief overview of tauopathy: causes, consequences, and therapeutic strategies","volume":"38","author":"Orr","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib60","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington's disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/fnl.10.41","article-title":"Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium","volume":"5","author":"Miller","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmolb.2019.00020","article-title":"Protein misfolding and ER stress in huntington's disease","volume":"6","author":"Shacham","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2022.01.020_bib66","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/pro.3499","article-title":"Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior","volume":"27","author":"Ghag","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib68","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00401-019-01973-6","article-title":"Demonstration of prion-like properties of mutant huntingtin fibrils in both in\u00a0vitro and in\u00a0vivo paradigms","volume":"137","author":"Masnata","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib69","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1038\/s41380-021-01055-8","article-title":"Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders","volume":"26","author":"de Rus Jacquet","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ymthe.2022.01.020_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.01.020_bib71","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.020_bib72","first-page":"838","article-title":"Screening for amyloid aggregation by semi-denaturing detergent-agarose gel electrophoresis","author":"Halfmann","year":"2008","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2022.01.020_bib73","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","article-title":"Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease","volume":"104","author":"Weiss","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib74","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","article-title":"Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks","volume":"7","author":"Shi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2022.01.020_bib75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.celrep.2018.09.076","article-title":"Human huntington's disease iPSC-derived cortical neurons display altered Transcriptomics, morphology, and maturation","volume":"25","author":"Mehta","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib76","doi-asserted-by":"crossref","first-page":"338ra366","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.020_bib77","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/Abeta42 predict cognitive decline in Parkinson's disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymthe.2022.01.020_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1468-1331.2009.02717.x","article-title":"Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study","volume":"17","author":"Rusina","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib79","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awx365","article-title":"Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years","volume":"141","author":"Albert","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2022.01.020_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal Ganglia and\u00a0cerebellum with vertical Gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.020_bib82","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington's disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fernandez-Nogales","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.020_bib83","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib84","doi-asserted-by":"crossref","first-page":"104569","DOI":"10.1016\/j.nbd.2019.104569","article-title":"Antibody-based therapies for Huntington's disease: current status and future directions","volume":"132","author":"Denis","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.01.020_bib85","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib86","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0196-9781(02)00261-9","article-title":"Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease","volume":"23","author":"Banks","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ymthe.2022.01.020_bib87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2022.01.020_bib88","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-020-00948-z","article-title":"Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation","volume":"8","author":"Zilkova","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2022.01.020_bib90","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","article-title":"Unconventional secretion mediates the trans-cellular spreading of tau","volume":"23","author":"Katsinelos","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib91","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","article-title":"Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways","volume":"22","author":"Evans","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib92","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.1523\/JNEUROSCI.3856-08.2008","article-title":"Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha","volume":"28","author":"Hulse","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ymthe.2022.01.020_bib94","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","article-title":"The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons","volume":"23","author":"Muratore","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.01.020_bib95","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in\u00a0vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2051-5960-2-14","article-title":"Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies","volume":"2","author":"Dujardin","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2022.01.020_bib97","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","article-title":"Fibrillar alpha-synuclein and huntingtin exon 1 assemblies are toxic to the cells","volume":"102","author":"Pieri","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.ymthe.2022.01.020_bib98","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2051-5960-1-82","article-title":"Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice","volume":"1","author":"Hoffmann","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2022.01.020_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fneur.2013.00114","article-title":"Are tau aggregates toxic or protective in tauopathies?","volume":"4","author":"Cowan","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib101","doi-asserted-by":"crossref","first-page":"14992","DOI":"10.1038\/srep14992","article-title":"Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect","volume":"5","author":"Sun","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.01.020_bib102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2022.01.020_bib103","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","article-title":"Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation","volume":"30","author":"Ortega","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington's disease","volume":"7","author":"Ortega","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib105","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cell.2017.09.009","article-title":"Huntingtin fibrils poke membranes","volume":"171","author":"Guedes-Dias","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.020_bib107","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in\u00a0vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.020_bib108","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1074\/jbc.M111.252577","article-title":"Identification of novel potentially toxic oligomers formed in\u00a0vitro from mammalian-derived expanded huntingtin exon-1 protein","volume":"287","author":"Nucifora","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.01.020_bib109","first-page":"e52434","article-title":"Use of the open field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2022.01.020_bib110","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0531-5565(02)00123-7","article-title":"Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on spatial learning, exploration, anxiety, and motor coordination","volume":"37","author":"Lalonde","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ymthe.2022.01.020_bib111","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2022.01.020_bib112","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.4854-06.2007","article-title":"Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia","volume":"27","author":"Planel","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.01.020_bib113","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2022.01.020_bib114","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162200020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162200020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:04:44Z","timestamp":1761501884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162200020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S152500162200020X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive immunization against phosphorylated tau improves features of Huntington's disease pathology","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}